1. "Hematologic Malignancies, Division of"
Formats
  1. Meeting Abstract (6210)
  2. Journal Article (5696)
  3. Review (405)
  4. Book Section (186)
  5. Editorial (186)
  6. Research Letter (169)
  7. Guidelines (86)
  8. Conference Paper (65)
  9. Correspondence (58)
  10. Miscellaneous (17)
  11. Book Whole (9)
Groups
  1. Hematologic Malignancies, Division of (13087)
  2. Department of Medicine (13003)
  3. Center for Hematologic Malignancies (10394)
  4. GSK Faculty (4421)
  5. Adult Leukemia (3582)
  6. Bone Marrow Transplant (2776)

More Groups

People
  1. Sergio Giralt (1050)
  2. Miguel-Angel Perales (913)
  3. Ross Levine (774)
  4. Andrew Zelenetz (767)
  5. Martin Tallman (649)
  6. Steven Horwitz (645)

More People

Years
  1. 2025 (203)
  2. 2024 (670)
  3. 2023 (1038)
  4. 2022 (964)
  5. 2021 (875)
  6. 2020 (936)

More Years

Publications
  1. Blood (3371)
  2. Journal of Clinical Oncology (1214)
  3. Biology of Blood and Marrow Transplantation (596)
  4. Clinical Lymphoma, Myeloma and Leukemia (328)
  5. Haematologica (289)
  6. Bone Marrow Transplantation (238)

More Publications

Publishers
  1. American Society of Hematology (3638)
  2. Elsevier Inc. (1609)
  3. American Society of Clinical Oncology (1266)
  4. Nature Publishing Group (994)
  5. American Association for Cancer Research (637)
  6. Wiley Blackwell (430)

More Publishers

Results (13087)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Distress and perceived impact on well-being for low- or intermediate-risk and high-risk patients with chronic lymphocytic leukemia (CLL)
    Meeting Abstract

    Buzaglo, J. S.; Miller, M. F.; Karten, C.; Weiss, E. S.; Tomlinson, B.; Andersen, B. L.; Matasar, M. J.; Byrd, J. C.; Flowers, C.
    Blood (2016)

    Fulltext@MSK | Save
  • Carfilzomib plus high dose melphalan conditioning prior to autologous hematopoietic cell transplantation followed by carfilzomib maintenance in patients with relapsed multiple myeloma
    Meeting Abstract

    Costa, L. J.; Landau, H.; Chhabra, S.; Hari, P.; Salzman, D.; Saad, A.; Innis-Shelton, R.; Hamadani, M.; Tamari, R.; Godby, K. N.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Novel associations between mutations, prognostic and clinical parameters in untreated progressive CLL: Data from E1912, a randomized phase III study of the ECOG-ACRIN Cancer Research Group
    Meeting Abstract

    Braggio, E.; Wang, V. X.; Garcia, S.; Bruins, L. A.; Lesnick, C.; Barrientos, J. C.; O'Brien, S. M.; Tallman, M. S.; Fonseca, R.; Kay, N. E.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • The Disease Risk Index predicts outcomes including relapse and survival in CD34-selected allogeneic HCT for acute leukemia and myelodysplastic syndrome
    Meeting Abstract

    Cho, C.; Hilden, P.; Peled, J. U.; Avecilla, S. T.; Barba, P.; Barker, J. N.; Castro-Malaspina, H. R.; Giralt, S. A.; Jakubowski, A. A.; Koehne, G.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • A phase 1b study investigating carfilzomib administered once weekly in combination with lenalidomide and dexamethasone in patients with multiple myeloma
    Meeting Abstract

    Biran, N.; Siegel, D. S.; Berdeja, J. G.; Faber, E.; Seneviratne, L.; Alsina, M.; Bensinger, W.; Kimball, A. S.; Zhou, K.; Landgren, O.
    Blood (2016)

    Fulltext@MSK | Save
  • A phase I/II open-label, dose escalation study to investigate the safety, pharmacokinetics, pharmacodynamics and clinical activity of GSK525762 in subjects with relapsed, refractory hematologic malignancies
    Meeting Abstract

    Borthakur, G.; Dawson, M. A.; Stein, E. M.; Karadimitris, A.; Huntly, B. J. P.; Dickinson, M. J.; Chaidos, A.; Horner, T.; Brennan, J.; Baron, J.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • The selective anti leukemic effect of BL-8040, a peptidic CXCR4 antagonist, is mediated by induction of leukemic blast mobilization, differentiation and apoptosis: Results of correlative studies from a Ph2a trial in acute myeloid leukemia
    Meeting Abstract

    Borthakur, G.; Tallman, M. S.; Ofran, Y.; Foran, J. M.; Uy, G. L.; DiPersio, J. F.; Nagler, A.; Rowe, J. M.; Showel, M. M.; Altman, J.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Outcomes of follicular lymphoma patients by dynamic FLIPI at diagnosis and initial treatment in the post-rituximab era
    Meeting Abstract

    Batlevi, C.; Alperovich, A.; Smith, K.; Ying, Z.; Soumerai, J. D.; Copeland, A. R.; Joffe, E.; Caron, P.; Drullinsky, P.; Gerecitano, J. F.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Outcomes of pharmacokinetically targeted busulfan-based conditioning regimen for patients with myelodysplastic syndrome and acute myelogenous leukemia undergoing CD34 selected allogeneic hematopoietic stem cell transplantation
    Meeting Abstract

    Beyer, K.; Proli, A.; Zheng, J.; Devlin, S.; Bhatt, V.; Lin, A.; Papadopoulos, E. B.; Jakubowski, A. A.; Perales, M.; Giralt, S.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • A distributed international patient data registry for hairy cell leukemia
    Meeting Abstract

    Andritsos, L. A.; Grever, M. R.; Anghelina, M.; Dearden, C. E.; Else, M.; Blachly, J. S.; Lele, O.; Ravandi, F.; Zent, C. S.; Johnston, J. B.; more...
    Blood (2016)

    Fulltext@MSK | Save